Black lung: an old disease that came back, and why silica is the reason

Start here: what black lung is

"Black lung" is the everyday name for coal workers' pneumoconiosis (CWP) — permanent scarring of the lungs caused by breathing coal mine dust over years of work. The mechanism is brutally simple. Dust particles small enough to reach the deepest part of the lung are engulfed by immune cells, which cannot digest mineral dust; the resulting chronic inflammation lays down fibrous scar tissue around the retained particles. Scar tissue does not exchange oxygen and does not stretch. The damage accumulates and does not reverse.

Doctors now describe a whole family of conditions under coal mine dust lung disease (CMDLD): coal workers' pneumoconiosis, silicosis, mixed dust pneumoconiosis, dust-related diffuse fibrosis (which can be mistaken for idiopathic pulmonary fibrosis), and chronic obstructive pulmonary disease ^[1]. Three facts about it should be stated at the outset, because everything else follows from them: it is incurable, treatment is symptomatic, and it is entirely preventable ^{[1] [2] [3]}.

Who gets it. Coal miners — and specifically miners with long tenure underground. The disease was supposed to be a historical problem. After the U.S. Coal Act, prevalence of the severe form fell sharply and reached historic lows in the 1990s ^[4]. As recently as the late 1990s the advanced form was, in the words of the surveillance programme's own investigators, "virtually eradicated," with a prevalence of 0.08% among all participants in the Coal Workers' Health Surveillance Program and 0.33% among active underground miners with at least 25 years of tenure ^[2].

It came back. By the most recent national surveillance analysis, CWP prevalence among working underground miners with 25 or more years of tenure exceeds 10%. In central Appalachia — Kentucky, Virginia, West Virginia — 20.6% of long-tenured miners have it: roughly one in five ^[5]. Excluding central Appalachia, prevalence for the rest of the United States is lower but has still increased since 2000 ^[5].

And it came back in its worst form, in younger men. The severe stage is progressive massive fibrosis (PMF), described by NIOSH investigators as "an advanced, debilitating, and lethal form of coal workers' pneumoconiosis with limited, primarily palliative treatment options and no cure" ^[2]. In 2016 a single eastern Kentucky radiology practice identified a cluster of 60 PMF cases in about 20 months — against 31 cases found by the entire national surveillance programme across the whole of 1990–1999. That cluster "was not discovered through the national surveillance program" ^[4]. Federal benefit claims tell the same story from a different direction: PMF cases among Black Lung Program claimants fell to 18 (0.6% of claimants) in 1988, then rose to 353 cases (8.3%) in 2014 ^[6].

Why it matters, and why it is in the news. This is a fatal, disabling disease with no cure, appearing in working-age men, in a country that had already solved it once. The leading explanation in the literature is not that miners are breathing more coal — it is that they are breathing more rock. That argument is the spine of this review, and it is developed in the Progress section with the pathology behind it.

Three pillars follow: measurements (how it is found and graded), management (which is mostly honest limits plus prevention), and progress (the resurgence, its silica explanation, and the policy response). Between the first two sits a simple exposure-response model that explains why cumulative dust exposure is the quantity that matters and why lowering a limit buys more than it appears to.

Pillar 1: measurements and diagnosis

The chest radiograph and the ILO classification

Black lung is found by imaging, not by symptoms — by the time a miner is short of breath, the scarring is established. The standard instrument is a plain chest radiograph, read against the International Labour Organization (ILO) classification of radiographs of pneumoconioses, which gives readers a fixed vocabulary and a set of standard reference films so that two doctors grading the same film reach comparable answers ^{[7] [8]}.

The classification turns on the size of what is visible:

• Small opacities — under 1 cm. Their density on the film is graded as a profusion category on a 12-point scale from 0/− to 3/+. The threshold for calling pneumoconiosis present is profusion 1/0 or greater. Their shape is also recorded, and this detail matters later: rounded opacities are lettered p, q, r by size, with r-type opacities (3–10 mm rounded) being the ones associated with silicosis pathology ^{[5] [8]}.
• Large opacities — greater than 1 cm. A large opacity is progressive massive fibrosis, and it is graded A, B, or C by size ^[5].

That single centimetre is the line between two very different diseases. Simple CWP means small opacities only: often no symptoms, often stable if exposure stops. PMF means the small lesions have coalesced into large masses of scar that destroy lung architecture — progressive, disabling, and lethal ^{[2] [9]}.

CT, and where the radiograph falls short

Computed tomography sees more. In 170 dust-exposed workers imaged both ways, CT signs of CWP were micronodules, nodules, and progressive massive fibrosis, and CT was superior to chest radiography for simple disease, with improved sensitivity for small parenchymal opacities — and it "clarifies some ambiguities of the ILO classification of small opacities" ^[10]. On thin-section CT the characteristic finding in silicosis and CWP is small nodules in a perilymphatic distribution, with or without eggshell calcification of lymph nodes; MRI can help distinguish PMF from lung cancer, which it can mimic ^[11]. The radiograph nonetheless remains the surveillance instrument, because surveillance has to be cheap, portable, and repeatable across tens of thousands of miners.

Breathing tests

Spirometry measures what the scarring costs. Dust disease can produce a restrictive pattern (stiff, small lungs — reduced FVC), an obstructive pattern (narrowed airways — reduced FEV₁/FVC), or both, interpreted against reference equations using standard strategies ^{[12] [13]}. The obstructive component is not incidental: accumulated evidence shows coal miners experience an excess of COPD, sufficient that chronic bronchitis and emphysema in coal miners are compensated as occupational disease in the UK and Germany ^{[14] [15]}, and occupational silica exposure independently causes COPD ^{[16] [17]}. Crucially, lung function loss tracks dust dose rather than radiographic category — in a cohort of U.S. miners who began work in or after 1970, cumulative exposure was associated with a loss of FVC and FEV₁ "of the order of 30 ml per mg/m³-years" ^{[18] [19]}.

What the dust does, and what the pathologist sees

The biology begins with a frustrated macrophage. Inhaled silica is sensed by the NALP3/NLRP3 inflammasome, triggering interleukin-1β secretion; activation is driven by reactive oxygen species generated by an NADPH oxidase when the particle is phagocytosed ^[20]. A parallel pathway involves STING-dependent sensing of self-DNA released by dying cells ^[21]. Downstream sits a cytokine network characterized specifically in silicosis and CWP ^{[22] [23]}, with oxidative stress and a self-reinforcing TGF-β/ROS cycle driving the fibrosis itself ^{[24] [25]}. Silica exposure also carries risks beyond the lung — tuberculosis, lung cancer, emphysema, autoimmune disease, and kidney disease ^{[26] [27] [28]}.

Under the microscope the distinction that matters is between coal-type lesions (coal macules and nodules), silica-type lesions (silicotic nodules), and mixed-dust lesions. That classification is not academic bookkeeping. It is the evidence on which the resurgence has been explained.

Centerpiece: a simple simulatable exposure-response model

The quantity that determines a miner's risk is not the dust concentration on any one shift, and not the number of years worked. It is the product of the two — cumulative exposure:

E = C × T

where C is the average respirable dust concentration in mg/m³ and T is years worked, giving E in mg/m³-years. A miner at 2 mg/m³ for 40 years and a miner at 4 mg/m³ for 20 years accumulate the same 80 mg/m³-years.

Risk is then modelled as a logistic function of that accumulated dose:

logit(p) = β₀ + β₁·E, equivalently p(E) = 1 / (1 + e^−(β₀ + β₁·E))

Grounding. This is the model form the U.S. National Study of Coal Workers' Pneumoconiosis actually used. Relating CWP prevalence to indexes of dust exposure from research and compliance sampling, "clear relationships between prevalences of both simple CWP and progressive massive fibrosis (PMF) and estimated dust exposure were seen," with additional independent effects of coal rank and age; logistic model fitting indicated that between 2% and 12% of miners exposed to a 2 mg/m³ dust environment in bituminous mines would be expected to have Category 2 or greater CWP after a 40-year working life, and PMF for between 1.3% and 6.7% ^[29]. A later cohort of 3,194 underground bituminous miners and ex-miners gave a companion estimate: miners of medium-to-low-rank coal working 40 years at the then-current federal dust limit of 2 mg/m³ are predicted to have a 1.4% risk of PMF on retirement ^[30].

Parameters. Each curve in the figure is pinned by exactly two constraints, so there is no fitting and no free parameter. The anchor at E = 80 mg/m³-years (40 years × 2 mg/m³) is taken from those grounded estimates: 12% for Category 2+ CWP (the upper end of the published range) and 1.4% for PMF. The background prevalence at zero exposure is illustrative and flagged — the source notes "a suggestion of a background level of abnormality, not associated with dust exposure, but increasing with age" but does not quantify it ^[29], so the values used (0.5% and 0.1%) are teaching choices, not published numbers.

What the model is for. One prediction, and it is the policy-relevant one: because the logistic curve is convex across this exposure range, cutting the dust concentration in half does far more than halve the risk. Halving the concentration over the same 40-year career takes predicted Category 2+ CWP from 12% to 2.6% — a 4.7-fold reduction — and predicted PMF from 1.4% to 0.4%. A regulator choosing an exposure limit is choosing a point on this curve, and the returns to a stricter limit are larger than linear intuition suggests.

That prediction is corroborated independently, with real data and a different disease endpoint. In a pooled analysis of six occupational cohorts, silicosis mortality rose in nearly monotonic fashion with cumulative silica exposure — from 4.7 per 100,000 person-years at 0–0.99 mg/m³-years to 233 per 100,000 above 28.1 mg/m³-years — and the estimated risk of silicosis death by age 65 after 45 years of exposure was 13 per 1,000 at 0.1 mg/m³ but 6 per 1,000 at 0.05 mg/m³. The authors noted both figures exceed the 1-per-1,000 risk usually deemed acceptable ^[31]. Comparable exposure-response analyses exist for Chinese tin miners ^[32], South African goldminers ^[33], diatomaceous earth workers ^[34], and quartz exposure in a Scottish colliery ^[35].

Limits, honestly. A two-parameter logistic through one anchor is a teaching object, not a risk assessment. Real analyses adjust for coal rank and age, both of which had independent effects ^{[29] [30]}; exposure estimates reconstructed from historical sampling carry real error, which the source authors flag themselves ^[29]; and the model treats all dust as equivalent, which — as the next section argues — is precisely the assumption that broke.

Pillar 2: management

This section is short, and its shortness is the point.

There is no cure. Fibrosis is scar tissue; nothing available reverses it. "Treatment of CMDLD is symptomatic. Those with end-stage disease are candidates for lung transplantation. Because CMDLD cannot be cured, prevention is critical" ^[1]. The parallel statement for silica is equally blunt: silicosis "is incurable but preventable… This debilitating and often fatal lung disease persists worldwide despite long-standing knowledge of its cause and methods for controlling it" ^[3].

Supportive care therefore targets symptoms and complications rather than the scarring: bronchodilators and the rest of the standard obstructive-disease toolkit where an obstructive component is present ^{[36] [37]}, oxygen for hypoxaemia, treatment of respiratory infections, and monitoring for the associated risks that come with silica exposure — notably tuberculosis, lung cancer, and kidney and autoimmune disease ^{[26] [27]}.

Pulmonary rehabilitation — supervised exercise training plus education — is the intervention with the best evidence for improving how patients actually feel and function. In COPD it improves health-related quality of life and exercise capacity ^{[38] [39]}, and it has been tested directly in this population: a randomized trial in 81 coal miners with stable stage II–III COPD evaluated a 12-week structured yoga-based rehabilitation programme for dyspnoea and fatigue ^[40]. Rehabilitation does not touch the fibrosis. It changes what a person can do with the lung they have left.

Lung transplantation is the only option for end-stage disease ^[1], and it is what it is everywhere: scarce, high-risk, and not a population-level answer.

Which leaves prevention as the only real lever. That is not a rhetorical flourish; it is the explicit conclusion of the clinical literature ^{[1] [3] [2]}. Prevention has two arms:

1. Exposure control — engineering controls on respirable dust and respirable crystalline silica at the face, and the exposure limits that force them. Regulation of engineering dust controls is "the primary preventative measure," and the review literature notes that evidence evaluating that regulation is thin even in high-income countries ^[7]. Where limits are set determines the point on the exposure-response curve an entire workforce is placed at ^{[29] [31]}. 2. Surveillance — periodic chest radiographs offered to miners so that disease is found while it is still simple CWP and further exposure can be stopped before it becomes PMF. This is the function of the U.S. Coal Workers' Health Surveillance Program ^{[2] [41]}, and comparable frameworks have been built or rebuilt elsewhere in response to their own outbreaks, including a Thoracic Society of Australia and New Zealand position statement calling for enhanced surveillance and a national occupational lung disease registry ^{[42] [43]}. Global reviews make systematic screening of at-risk miners and a central registry a public-health priority, while noting it is limited by financing in less developed countries ^[7].

The eastern Kentucky cluster is the cautionary tale for arm 2: 60 PMF cases found by one radiology practice, and "this cluster was not discovered through the national surveillance program" ^[4]. A surveillance system that miners do not participate in does not protect them.

Pillar 3: progress — the resurgence, and the silica explanation

The observation

Severe disease started reappearing in the 2000s, and it appeared fast and young. Reviewing federal radiograph surveillance from 1996 to 2002, investigators identified 886 CWP cases among 29,521 miners examined; among the 783 whose progression could be evaluated, 277 (35.4%) met the definition of rapidly progressive CWP — development of PMF, or an increase of more than one profusion subcategory within five years — and miners with rapidly progressive disease were younger than those without. Cases clustered geographically ^[44]. That combination — young, fast, and geographically concentrated — was the anomaly. Classic CWP is a slow disease of long careers.

The hypothesis

The obvious suspect was not coal but respirable crystalline silica (quartz). As central Appalachian seams thinned, extracting the coal meant cutting through more of the surrounding rock, and rock is where the quartz is. Dust generated by cutting sandstone is far more fibrogenic, gram for gram, than dust generated by cutting coal.

The first radiographic evidence was indirect but pointed. Examining chest radiographs from 90,973 miners over 1980–2008 for r-type small opacities — the rounded 3–10 mm opacities associated with silicosis pathology — investigators found the proportion showing r-type opacities increased among Kentucky, Virginia and West Virginia miners during the 1990s (prevalence ratio 2.5) and again after 1999. The paper's title asks the question directly: is silicosis becoming more frequent? ^[8]

The pathology settled it

Radiographs can only suggest. Lung tissue answers.

An initial series of 13 miners with rapidly progressive pneumoconiosis found that many had features of accelerated silicosis and mixed dust lesions; 12 had PMF and 11 had silicosis ^[45]. A much larger comparison then examined lung pathology from 85 coal miners with PMF, splitting them into a historical cohort (born 1910–1930) and a contemporary one (born 1930 or later). The contemporary miners had a significantly higher proportion of silica-type PMF: 57% versus 18% (P < 0.001). Mineral dust alveolar proteinosis was also more common (70% vs 37%), and in-situ mineralogic analysis showed both a higher percentage (26.1% vs 17.8%) and higher concentration of silica particles in contemporary miners' lungs ^[46]. Independent work using the National Coal Workers' Autopsy Study classified 322 PMF cases as 43% coal-type, 40% mixed-type and 17% silica-type, and found coal- and mixed-type rates declining across birth cohorts while silica-type rose ^[47].

So the resurgence is not simply "more dust." It is different dust — a shift in the mineralogy of what miners inhale, which the older exposure-response models, calibrated on coal dust with coal rank as the modifier, were never built to capture ^{[29] [48]}. Contemporary miners with PMF also differ from their historical counterparts in tenure and job duties ^[49], and the disease has concentrated in smaller underground operations ^[50].

The policy response, and the parallel epidemic

The regulatory implication is direct: if silica is the driver, then a respirable crystalline silica limit — not just a total respirable dust limit — is the control that matters. The exposure-response literature has been explicitly aimed at informing that standard, from quartz-specific colliery reanalyses intended "to inform the debate on an appropriate occupational standard for respirable quartz" ^[35] to the pooled cohort analysis showing that risks at commonly used silica standards exceed conventionally acceptable levels ^[31], on a hazard base NIOSH had already reviewed ^[3]. Internationally, rising CWP diagnoses have forced reviews of recommended respirable dust exposure limits, with the observation that limits and monitoring protocols should ideally be standardized ^[7].

The urgency is sharpened by a second silica epidemic running in parallel, in a completely different industry. Engineered stone countertop fabrication exposes workers cutting a quartz-based composite that can contain more than 90% crystalline silica; outbreaks of severe, rapidly progressive silicosis — including the first U.S. fatalities — have been reported across several states and countries, disproportionately among immigrant workers ^{[26] [51] [52] [53]}. It is the same mineral, the same mechanism, the same absence of a cure, and the same surveillance gap ^[54].

Where detection is heading

Because surveillance rests on reading enormous numbers of chest radiographs consistently, it is a natural target for automation. A deep-learning model for pneumoconiosis screening and staging reported screening accuracy of 0.973 with sensitivity and specificity both above 0.97, and staging accuracy of 0.927 on an independent test cohort ^{[55] [56]}. The bottleneck this addresses is real — reader capacity and consistency — but it does not address the one the Kentucky cluster exposed, which was miners not being in the surveillance system at all ^[4].